HYBD - HYCOR BIOMEDICAL INC.
(recommended to subscribers on 1/05/03 at $2.00)

    Hycor Biomedical Inc., a maker of medical diagnostic products, reported for the quarter ending September 30th 2002, sales of $4.5 million and net income of $332,000 or 4 cents per share.  Revenues and earnings were up over the same quarter last year.  For the first nine months of 2002 revenues were $13.8 million with net income of $993,000 or 12 cents a share.  On October 11th the company announced a potential buyback of up to 1 million shares (14% of the float). 

    HYBD has a tangible book value of $1.57 per share.  They have $5.6 million in cash and short term investments with $1 million in long- term debt.  HYBD trades at a little under 1x sales with a tiny market cap of 16 million.

Update 5/16/03 - Recommend selling at the current price of $3.84. This gives you a gain of 92%.
 

    Next Pick                          Back to Closed Positions